Development of combination methods with dendritic cells and novel chemokine products for preventing hepatocellular carcinoma recurrence
Project/Area Number |
23659396
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Gastroenterology
|
Research Institution | University of Fukui |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 癌 / 免疫学 / トランスレーショナルリサーチ / 動物 / 内科 / トランスレーショナルリサーチ |
Research Abstract |
The current study was designed to develop the combination methods with dendritic cells and novel chemokine products for preventing the recurrence of hepatocellular carcinoma following the treatments. The methods of dendritic cell induction were modified using OK-432 and zinc, and the chemokine products were evaluated for the activation of the cancer immunity. Furthermore, the biological stability of the products was improved by recombinant technology. Collectively, the results indicated that the modified methods using both dendritic cells and the chemokine products may contribute to the reduction of hepatocellular carcinoma recurrence.
|
Report
(4 results)
Research Products
(29 results)
-
[Journal Article] Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.2014
Author(s)
Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang XW, Kaneko S
-
Journal Title
Hepatology
Volume: in press
Issue: 5
Pages: 1674-85
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis.2014
Author(s)
Miyake Y, Yamamoto K, Matsushita H, Abe M, Takahashi A, Umemura T, Tanaka A, Nakamuta M, Nakamoto Y, Ueno Y, Saibara T, Takikawa H, Yoshizawa K, Ohira H, Zeniya M, Onji M, Tsubouchi H; Intractable Liver and Biliary Diseases Study Group of Japan
-
Journal Title
Hepatol Res.
Volume: in press
Issue: 13
Pages: 1299-1307
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.2014
Author(s)
Nakagawa H, Mizukoshi E, Iida N, Terashima T, Kitahara M, Marukawa Y, KitamuraK, Nakamoto Y, Hiroishi K, Imawari M, Kaneko S
-
Journal Title
Cancer Immunol Immunother.
Volume: 63(4)
Issue: 4
Pages: 347-356
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Correction : TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors2013
Author(s)
Miwa S, Nishida H, Tanzawa Y, Takata M, Takeuchi A, Yamamoto N, Shirai T, Hayashi K, Kimura H, Igarashi K, Mizukoshi E, Nakamoto Y, Kaneko S, Tsuchiya H
-
Journal Title
PLoS One (eCollection 2013.)
Volume: 24
Pages: 8-8
Related Report
Peer Reviewed
-
[Journal Article] Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients.2013
Author(s)
Masamichi Ikawa, Makoto Yoneda, Tomoko Muramatsu, Akiko Matsunaga, Tetsuya Tsujikawa, Tatsuya Yamamoto, Nobuyuki Kosaka, Kazuyuki Kinoshita, Osamu Yamamura, Tadanori Hamano, Yasunari Nakamoto, Hirohiko Kimura
-
Journal Title
Mitochondrion
Volume: 13(6)
Issue: 6
Pages: 676-680
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Clinical relevance and sequence analysis of the Helicobacter pylori dupA region from two areas in Japan with different gastric cancer risks2012
Author(s)
Matsuda H, Ito Y, Suto H, Yamakawa A, Satomi S, Ohtani M Yamazaki Y, Kusaka Y, Shimabukuro Y, Kikuchi K, Keida Y, Azuma T, Nakamoto Y
-
Journal Title
Immuno-Gatroenterology
Volume: 1:2
Pages: 127-135
URL
Related Report
Peer Reviewed
-
-
-
[Journal Article] Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update2012
Author(s)
Kaneko S, Furuse J, Kudo M, Ikeda K, Honda M, Nakamoto Y, Onchi M, Shiota G, Yokosuka O, Sakaida I, Takehara T, Ueno Y, Hiroishi K, Nishiguchi S, Moriwaki H, Yamamoto K, Sata M, Obi S, Miyayama S, Imai Y
-
Journal Title
Hepatol. Res
Volume: 42
Issue: 6
Pages: 523-542
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization2011
Author(s)
Nakamoto Y, Mizukoshi E, Kitahara M, Arihara F, Sakai Y, Kakinoki K, Fujita Y, Marukawa Y, Arai K, Yamashita T, Mukaida N, Matsushima K, Matsui O, and Kaneko S
-
Journal Title
Clin Exp Immunol
Volume: 163(2)
Issue: 2
Pages: 165-177
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma2011
Author(s)
Takata Y, Nakamoto Y, Nakada A, Terashima T, Arihara F, Kitahara M, Kakinoki K, Arai K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Kaneko S
-
Journal Title
Cancer Lett
Volume: 307
Issue: 2
Pages: 165-173
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
[Presentation] Increase of CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma and its impact for prognosis of patients2011
Author(s)
Arihara F, Mizukoshi E, Kitahara M, Takata Y, Arai K, Yamashita T, Nakamoto Y, Kaneko S
Organizer
第62回American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Place of Presentation
San Francisco, California, Hepatology 54 (4,Suppl.) 1400A
Year and Date
2011-11-08
Related Report
-
-
-